Addex Therapeutics Ltd
F:APE1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Addex Therapeutics Ltd
F:APE1
|
CH |
|
E
|
Energeia AS
F:F62
|
NO |
|
L
|
LiqTech International Inc
F:39J
|
DK |
|
W
|
WashTec AG
XMUN:WSU
|
DE |
|
Kromek Group PLC
F:4KM
|
UK |
|
S
|
Santen Pharmaceutical Co Ltd
OTC:SNPHY
|
JP |
|
Kerlink SA
F:344
|
FR |
|
Yaskawa Electric Corp
F:YEC0
|
JP |
|
O
|
Okinawa Electric Power Co Inc
OTC:OKEPF
|
JP |
|
Renew Holdings PLC
F:LLP
|
UK |
|
O
|
Odonate Therapeutics Inc
OTC:ODTC
|
US |
|
Quoin Pharmaceuticals Ltd
F:2EB0
|
IL |
Shareholder Yield
Current shareholder yield for 
APE1 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
APE1 Price
Addex Therapeutics Ltd
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -40% |
| Market Capitalization | 3.4m EUR |
| Shares Outstanding | 218 650 000 |
| Percentage of Shares Shorted |
N/A
|
